Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure, as well as several earlier stage assets. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs. 

The Senior Manager, FP&A is responsible for driving company‑wide financial planning, leading core FP&A cycles, and overseeing the systems that enable enterprise financial reporting and analytics. This role partners closely across Finance, Accounting, IT, and global business teams to deliver accurate, insightful financial information and equip senior leadership with the tools and analysis required for informed decision‑making. The role also serves as the owner of the company’s management reporting tools, ensuring data integrity, system optimization, and seamless integration of planning, reporting, and forecasting activities. This role will report to the Senior Director, FP&A.

A successful candidate for this role is a proactive, self‑starter who brings deep knowledge of financial reporting best practices and strong understanding of financial operations. They independently lead complex financial system management, continually assess processes, and implement improvements as business needs and technologies evolve. This individual demonstrates strong problem‑solving skills, an entrepreneurial and solutions‑oriented mindset, and the ability to work cross‑functionally to raise issues, deliver insights, and drive efficiencies. They communicate clearly and concisely with peers, business partners, and senior leadership, consistently elevating the quality and impact of FP&A across the organization.

Key Responsibilities

• Lead quarterly FP&A processes, including financial consolidation, variance analysis, and preparation of management and board review materials
• Own the company-wide annual operating plan and mid‑year forecast processes, ensuring alignment with strategic priorities across global functions
• Partner with Commercial and R&D finance partners to understand and consolidate financial results and drivers
• Serve as the company’s FP&A Systems leader, owning Adaptive Insights and acting as the primary liaison with IT to ensure integration with SAP Cloud
• Leverage financial tools and systems to prepare monthly and quarterly reporting for departments, including Adaptive, SAP Cloud, and Alanda, and champion automation and process improvements to enhance insight and reduce manual effort
• Develop and oversee financial models, including ad‑hoc analyses, business case development, cost optimization assessments, to support tactical and strategic decisions
• Support integration activities related to acquisitions, including FP&A process alignment, financial systems integration, and consolidation of planning models

Qualifications & Experience

• Bachelor’s degree in Finance or Accounting required; MBA, MS Finance, or CPA/CFA preferred.
• 8–10 years of progressive FP&A experience, including ownership of budgeting, forecasting, financial modeling, and executive‑level financial analytics.
• Strong experience with financial systems (Adaptive Insights strongly preferred, SAP preferred)
• Demonstrated ability to lead company‑wide planning processes, including annual operating plans, forecasts, long‑range planning, and cross‑functional reviews.
• Advanced financial modeling and analytical skills, with a track record of supporting strategic decisions, business cases, partnerships, and/or M&A–related financial assessments.
• Strong understanding of P&L, balance sheet, and cash flow mechanics, and how they interact across Commercial, G&A, and R&D functions.
• Ability to partner effectively with senior leadership, communicate complex financial information clearly, and influence decision‑making.
• Experience working in environments requiring SOX compliance, financial controls, and cross‑functional collaboration with Accounting, IT, and business partners.
• Proven ability to drive process automation, system optimization, and continuous improvement within FP&A workflows.

Ironwood is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or protected veteran status.

Ironwood currently anticipates that the initial base salary for this position could range from between $148,000K - $176,715. The actual base salary will depend, in part, on the successful candidate’s qualifications for the role, including education and experience.  Ironwood offers a comprehensive compensation and benefits program to eligible employees, including Restricted Stock Unit awards; eligibility to participate in either a bonus or sales incentive program; company-sponsored 401(k) with matching contributions; eligibility for medical, dental, vision and prescription drug benefits; wellness stipends; and a generous vacation/holiday schedule.

#LI-Hybrid

Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure, as well as several earlier stage assets. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.

Purpose/Summary:

This position is responsible for all aspects of Chemistry, Manufacturing, and Controls (CMC) drug product development from early stage to late-stage clinical development and commercialization, including development of efficient and scalable manufacturing processes, technology transfer, manufacturing of clinical supplies, and management of supply chain for clinical supplies. She/he is also responsible for preparation and review of all CMC regulatory filings. 

At this stage, the primary activities are focused on supporting Phase 3 clinical trials, including manufacturing clinical supplies, managing resupply needs, and overseeing the clinical trial supply chain and drug/device combination product interface.

The Head of Drug Product Development leads activities of an internal multifunctional team and network of external Contract Development and Manufacturing Organization (CDMO) partners working on all aspects of CMC development.  Functional responsibilities as project leader include formulation and manufacturing process development, oversight of drug product development, technology transfer and scale-up, and oversight of packaging and labeling, clinical supply chain, and CMC project management for drug product and drug/device combination product interface related activities.  Must possess strong leadership experience including strong CMC expertise and good technical understanding of the inter-disciplinary nature of drug development demonstrated by previous experience with injectables and drug/device combination products. She/he will collaborate closely with cross-functional internal and primarily external (CDMOs) team members in CMC development, Regulatory, Quality, Clinical Operations and Development during all phases of product development Ph 1- Ph 3, technology transfer, validation, manufacturing and filing IND, IMPD, NDA, MAA registration.

Essential Functions:

• Lead internal and CDMO Drug Product teams and represent Drug Product Development in multidisciplinary project teams as a project leader, work collaboratively to ensure project progression, and communicate Tech Ops strategy and related challenges.
• Encourage innovative, cross-functional thinking, and engagement of outside expertise as appropriate to help further Tech Ops/Corporate goals
• Ensure robust planning and execution of product development efforts across Ironwood's portfolio of development candidates from IND, Ph1, Ph2, Ph3 to commercialization. Proactively identify and mitigate risks to advance products in a timely manner.
• Ensure effective communication with key partners internally (particularly program management, regulatory, clinical development, and quality) and with an external CDMO network.
• Set Drug Product team budget and have financial accountability for drug product development activities per the annual operating plan.
• Responsible for Drug Product CDMOs timelines and Drug Product functional planning by providing technical oversight to ensure that Ironwood’s development and clinical manufacturing needs are met.
• Provide oversight to the clinical trial supplies team managing the inventory/delivery of Investigational products.
• Apply formulation and manufacturing principles, theories, and techniques to product development, and ensure development of the best possible phase-appropriate formulations.
• Supervise Drug Product and Clinical trial Supply scientists internally and externally to deliver on chemical, formulation, and analytical drug product development goals.
• Enable risk-based and compliant development practices: Identify and evaluate risks and provide recommendations to close via internal or external collaborations. Ensure development activities are documented per Ironwood documentation policies and underlying data are traceable.
• Author and/or review technical reports and relevant CMC sections for regulatory submissions (INDs, IMPDs, NDAs, etc.). Accountable for content development of FDA and exUS regulatory filings in collaboration with Regulatory, Quality, Supply Chain and members of the Development teams.

Requirements:

• PhD in pharmaceutical sciences, chemical or biochemical engineering, chemistry, or related scientific field with at least 15 years of industrial experience with at least 10 years of senior leadership experience in leading CMC/formulation teams especially in the injectable space (more specifically vials, both liquid and lyophilized drug products).
• Experience with injectable drug products containing synthetic peptides.
• Experience with leading drug product teams for injectable products during Phase 3, process validation, launch readiness and transition to commercial production.
• Experience with early phase development (pre-clinical, and Phase 1) a plus.
• Demonstrated experience supporting drug–device combination product development, with specific expertise in fill‑finish processes (e.g., prefilled syringe, autoinjector, dual-chamber cartridge) and conducting drug product–device / container compatibility evaluations.
• Experience with clinical studies and supply chain management oversight a plus.
• Comprehensive understanding of all aspects of CMC including process and formulation development, analytical science, regulatory, and quality.
• Strong group leadership, communication, and collaborative skills (both cross-department and with development partners). Experience working with global teams is strongly desired 
• Experience in managing development and manufacturing activities at global CDMOs
• Experience with synthetic peptide manufacturing processes, injectable drug product manufacturing, and finished goods primary packaging 
• Working knowledge of approaches for characterization of solution and solid-state properties of materials, and technologies for delivery of synthetic peptides
• Excellent data analysis skills and the ability to make recommendations that impact the scientific and business goals of the company. Ability to articulate complex issues and ideas with clarity to enable understanding and direction.
• Solid understanding of ICH, FDA, EMEA and USP guidelines is essential, including the ability to apply the guidelines in context of the stage of product development
• Strong understanding of drug–device combination product development, including primary container interactions, fill‑finish considerations, and drug product–device compatibility
• Experience with submissions and interactions with regulatory agencies regarding CMC issues during product development and primary container/packaging for drug-device combination products. Thorough knowledge of INDs, IMPDs, MAAs, NDAs, etc.
• The ability to work successfully in both a team/matrix environment as well as independently is required
• The ability to influence cross-functionally to enable development improvements and team performance.
• Good communication, project management, and interpersonal skills
• Effective and innovative problem-solving skills

Ironwood Pharmaceuticals is an equal opportunity employer welcoming diversity in our workforce.

Ironwood currently anticipates that the initial base salary for this position could range from between $246,000 to $286,650.  The actual base salary will depend, in part, on the successful candidate’s qualifications for the role, including education and experience.  Ironwood offers a comprehensive compensation and benefits program to eligible employees, including Restricted Stock Unit awards; eligibility to participate in either a bonus or sales incentive program; company-sponsored 401(k) with matching contributions; eligibility for medical, dental, vision and prescription drug benefits; wellness stipends; and a generous vacation/holiday schedule.

#LI-Hybrid

Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure, as well as several earlier stage assets. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.

The Senior Director of Investor Relations and Corporate Communications will develop and execute the company’s corporate communications strategy, with a strong focus on external communications, investor relations, and internal communications. This position will be responsible for developing and delivering key messages across various channels, supporting the creation of content for investor relations and corporate presentations, and ensuring alignment across the organization. The Senior Director will play a pivotal role in maintaining the company’s public narrative, ensuring the company’s website is current, and proactively managing corporate messaging with internal and external stakeholders.

This person will play a leadership role in developing and executing an effective investor relations program and engaging with the investment community, serving as a key company contact. This person will also act as a trusted internal adviser to the executive team and the Board, sharing perspectives and feedback on investor feedback and sentiment.

This role will report to the Chief Financial Officer.

Key Responsibilities

Investor Relations:

• Design and implement an effective investor relations program that enhances understanding of and confidence in Ironwood’s vision, mission and strategy among members of the investment community;
• Develop a thorough understanding of Ironwood’s business and strategy to effectively communicate the company’s execution in a clear and compelling manner;
• Build and strengthen relationships with current and prospective investors;
• Provide analytics and tracking – including the quarterly stock activity report, research analysts’ valuations and financial models, investor perceptions, among other market intelligence – to help facilitate enhanced engagement with investment community;
• Implement strategic investor and analyst targeting program directed at helping the company to maximize long-term value;
• Lead development of materials for quarterly and annual earnings results, including press release, conference call scripts, slides, key messages and Q&A;
• Lead development of press releases, PowerPoint presentations and other investor communications

Corporate Communications:

• Corporate Communications Strategy: Develop and implement a comprehensive corporate communications strategy that aligns with the company’s vision, values, and business goals. Manage both internal and external communications, ensuring consistency and clarity across all channels.
• Content Creation: Write and produce high-quality content for various corporate materials, including press releases, blog posts, newsletters, annual reports, and executive communications. Ensure messaging aligns with the company’s corporate narrative and business objectives.
• Media Relations: Cultivate relationships with key media outlets, journalists, and industry influencers to secure media coverage and promote the company’s achievements. Respond to media inquiries and ensure timely and accurate responses.
• Crisis Communication and Reputation Management: Support the development of crisis communication plans and manage media inquiries, as applicable. Monitor and manage the company’s reputation in both traditional and social media.
• Website Management and Content Development: Oversee the company’s website, ensuring it is up to date with the latest company developments, research updates, clinical trials, investor relations content, and other corporate information. Collaborate with cross-functional teams to create fresh, engaging content that represents the company’s innovations and achievements.
• Cross-functional Collaboration: Coordinate the creation of a unified communication calendar to align efforts, key dates, and messages across departments.
• Internal Communications: Develop and implement effective internal communications strategies to keep employees informed and engaged with company developments, milestones, and leadership updates. Foster a positive internal culture through transparent and consistent communication.

Qualifications

• Minimum of 15+ years of work experience in investor relations and corporate communications within the pharmaceutical, biotechnology, or healthcare industries.
• Bachelor's degree; MBA preferred but not required.
• Strong knowledge of pharmaceutical industry trends, clinical development processes, and investor relations practices.
• Proven ability to develop and implement strategic communication plans, including writing, editing, and creating content for a variety of formats.
• Experience in managing corporate websites and digital content, with a focus on maintaining up-to-date, engaging content.
• Familiarity with regulatory and compliance guidelines related to corporate and investor communications in the pharmaceutical industry.
• Excellent written and verbal communication skills, with a talent for crafting clear, concise, and persuasive messages.
• Strong project management and organizational skills, with the ability to manage multiple priorities and deadlines.
• Ability to collaborate effectively across functions and manage complex stakeholder relationships.
• Experience working with executives and preparing presentations and materials for external and internal audiences.
• High degree of professionalism and confidentiality, with an ability to handle sensitive information responsibly.
• Ability to think strategically and proactively manage communications needs across the organization.
• Travel requirement up to 20%

Ironwood Pharmaceuticals is an equal opportunity employer welcoming diversity in our workforce.

Ironwood currently anticipates that the initial base salary for this position could range from between $246,000 to $286,650.  The actual base salary will depend, in part, on the successful candidate’s qualifications for the role, including education and experience.  Ironwood offers a comprehensive compensation and benefits program to eligible employees, including Restricted Stock Unit awards; eligibility to participate in either a bonus or sales incentive program; company-sponsored 401(k) with matching contributions; eligibility for medical, dental, vision and prescription drug benefits; wellness stipends; and a generous vacation/holiday schedule.

#LI-Hybrid

Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs. 

Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts, and has operations in Basel, Switzerland.

Purpose/Summary: The Clinical Operations Lead owns program delivery & operational CRO/vendors oversight oof one or more development programs.

The Clinical Operations Lead has hands-on accountability and responsibilities in overseeing clinical trials execution within the program(s), especially the oversight of the trials/Program CRO, consultants and contractors to secure excellence in the delivery of their services to meet the trial milestones while adhering to quality, timeline, and budget. Leads by example with strong partnering and communication capabilities.

Key responsibilities:

• Takes a lead role in managing clinical program(s) and collaborating globally and across departments such as clinical development, regulatory, data management, biostatistics, drug supply, medical writing, and drug safety, etc.
• Supports creation and maintenance of the clinical development plan in collaboration with the Clinical Development Lead by providing input on operational aspects of the program and trials, including, but not limited to, budget, timelines, and vendors.
• Oversees CTT performance, including metrics, milestones and compliance with relevant regulatory standards, including ICH‑GCP, protocol requirements and company procedures.
• Collaborates with the Global Clinical Trial Managers (gCTM) and functions in the following activities, among others:
  • Support decision-making in the selection of study
  • oversight of CROs, vendors, consultants and contractors, including negotiation of Scope of work (SOW), ensuring delivery against contracted SOW, budgets, performance management and issue
  • Development and management of program timelines, budgets and
  • Oversight of trial subject retention
• Constantly scans for possible risks and implementation of mitigations; while identifying best practices and opportunities for trial efficiencies and opportunities for enhanced quality.
• Leads by example, onboarding, coaching, and mentoring other Development Operations team members, , fostering a team culture of ownership, engagement, and continuous improvement, ensuring recognition of team successes.
• Provides immediate supervision and line management to one or more employees, , including employee development, company goal setting, and performance management processes.
• Contributes to strategic vision and long-term plans of Development
• Supports in determining the best utilization and prioritization of resources, and the optimal organization of infrastructure and staff, leveraging experience working in varying resource models (i.e. Hiring, Functional Service Provider, CRO Full Package Outsourcing, etc.).
• Identifies and eliminates any impediments that obstruct or distract the team from delivering value; report and escalate issues, concerns, and roadblocks to management as needed.
• Regularly interacts with senior management on matters concerning functional areas and/or vendors.
• Contributes with the development and implementation of policies and standard operating procedures (SOPs) to be used in Development Operations
• Other duties as assigned

Prerequisite Education, Experience, & Skills:

• A highly motivated and results-oriented leader with a Bachelor’s degree and 14 years of pharmaceutical/Biotech clinical development and operations experience.
• Broad experience in global level clinical trial management, and knowledge of principles and practices of Program and Project Management. 
• Significant experience managing all aspects of activities in Phase I-IV trials, oversight of CROs and vendors at global level.
• Advantageous to have rare disease trial experience.
• Proven ability to effectively manage a large team comprised of permanent employees, consultants, contractors and oversight/partnering with CROs and teams within their varying levels.
• Intense drive and organizational expertise are necessary to manage the diverse group of functional activities involved in the international clinical trials program.
• Strong proficiency in GCP/ICH, U.S. drug development process and regulatory expectations related to global clinical trials execution .
• Excellent interpersonal, oral, and written communication skills.
• Ability to drive high-level decision-making, think strategically, and take initiative in the face of incomplete information
• Able to motivate teams to do their best work through active collaboration, healthy debate, and continued learning.

Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure, as well as several earlier stage assets. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs. 

Purpose / Summary:

Reporting to the Head of Regulatory Affairs CMC, the Director, Global Regulatory Affairs – CMC is responsible for owning and leading the global CMC regulatory strategy and execution to enable clinical development, commercialization, and lifecycle management of the company’s products. This individual ensures that global CMC regulatory requirements are proactively identified, strategically addressed, and fully integrated into development and commercial plans.

The Director serves as the single-point CMC regulatory lead for assigned programs, accountable for regulatory strategy, health authority engagement, submission quality, and inspection readiness. This role requires close collaboration with senior leadership and cross-functional stakeholders to define regulatory objectives, manage risk, and support timely, high-quality global submissions and approvals.

Essential Functions:

• Lead and own the global CMC regulatory strategy for assigned programs across development, registration, and lifecycle management, identifying key risks, remediation activities, and opportunities for acceleration while ensuring approvability and inspection readiness.
• Serve as the regulatory CMC representative on internal CMC teams, core submission teams, and cross-functional governance forums, providing authoritative regulatory input and decision-making support.
• Provide strategic global Regulatory Affairs–CMC guidance to project teams and ensure timely development and execution of integrated regulatory project plans.
• Assess, interpret, and communicate global CMC regulatory requirements to ensure all development and commercial activities comply with applicable regulations, guidelines, and regional expectations.
• Initiate, lead, and strategically manage interactions with global health authorities (FDA, EMA, PMDA, and other national competent authorities) to obtain alignment on CMC strategy, negotiate data requirements, resolve issues, and support timely approvals.
• Lead preparation of high-quality CMC briefing packages and regulatory narratives for health authority meetings, including definition of regulatory positions, risk mitigation strategies, and alignment of supporting data; participate in or lead agency interactions as a key spokesperson.
• Provide strategic regulatory leadership for GMP inspections and PAI readiness, including inspection preparation, response strategy, and alignment of regulatory commitments with Quality and Tech Ops execution.
• Coordinate, review, and be accountable for the quality and timeliness of global CMC regulatory submissions and lifecycle filings, including original INDs, CMC amendments, IMPD amendments, annual reports, meeting requests, briefing packages, marketing applications, and post-approval changes.
• Work directly with external contractors and collaborators, managing regulatory deliverables, communication pathways, and project plans to ensure accuracy, compliance, and executional success.
• Establish and lead CMC regulatory governance for assigned programs, including defining review cadence, risk escalation pathways, and communication of status, risks, and decisions to senior leadership and executive management.
• Remain current on evolving global regulations, standards, policies, and guidance issued by relevant regulatory authorities and assess impact to development and commercial programs.
• Partner with cross-functional stakeholders to proactively identify, escalate, and resolve CMC regulatory issues impacting development timelines or approval readiness.

Requirements:

• Bachelor’s degree in a scientific discipline such as Biology, Chemistry, or Pharmaceutical Sciences; advanced degree preferred.
• Minimum of 10 years of progressively increasing responsibility in CMC Regulatory Affairs within the biopharmaceutical industry.
• Demonstrated experience leading successful global marketing application submissions and approvals.
• Proven experience preparing CMC sections of global clinical trial applications (IND, IMPD, CTA).
• Experience with drug-device combination products preferred.
• Demonstrated ability to develop and defend CMC regulatory strategies supporting new product development, commercialization, and lifecycle management.
• Strong track record of successful global regulatory interactions and submissions for biologics, innovative medicines, and/or combination products in the US, EU, and other regions.
• Demonstrated ability to provide risk-based regulatory decision-making and strategic recommendations to senior leadership.
• Strong leadership, communication, and interpersonal skills with the ability to influence decision-making diplomatically across functions.
• Ability to work independently and effectively within matrixed, cross-functional teams and with external partners.
• Excellent written and verbal communication, organizational, and project management skills.
• Ability to operate in a fast-paced environment while managing multiple priorities.

Ironwood is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or protected veteran status.

Ironwood currently anticipates that the initial base salary for this position could range from between $208,000K - $243,600K. The actual base salary will depend, in part, on the successful candidate’s qualifications for the role, including education and experience.  Ironwood offers a comprehensive compensation and benefits program to eligible employees, including Restricted Stock Unit awards; eligibility to participate in either a bonus or sales incentive program; company-sponsored 401(k) with matching contributions; eligibility for medical, dental, vision and prescription drug benefits; wellness stipends; and a generous vacation/holiday schedule.

#LI-Hybrid